Subanesthetic dose ketamine infusions have been well studied with good outcomes for
multiple pain conditions, including complex regional pain syndrome, fibromyalgia and
acute on chronic pain with opiate tolerance. This study examined the effect of subanesthetic
dose ketamine infusions on patients suffering from chronic migraine (CM) or new daily
persistent headache (NDPH) who had pain that was refractory to other treatments.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Emergency MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2017 Published by Elsevier Inc.
